Evidence map›Paper›PMID 30767000›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2019

Progress in Typhoid Fever Epidemiology.

John A Crump

Registry-linked trialAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04673487 (Comparative Study of Commercially Available Typhoid Point of Care Tests to Benchmark Current and Emerging Tools), which is not on this map. Cited by 84 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04673487 unknown statusnot on this mapstarted 2021, after this paper: background citation

Comparative Study of Commercially Available Typhoid Point of Care Tests to Benchmark Current and Emerging Tools

TypeobservationalSponsorKenya Medical Research InstituteRan2021 to 2021Enrolled2,000ConditionsTyphoid FeverArms1. SD Bioline Salmonella Typhi IgG/IgM Fast test, 2. Typhidot Rapid IgG/IgM combo test, 3. TUBEX TF test, 4.Typhoid IgG/IgM Combo Rapid Test CE, 5. Enterocheck WB test, 6. Test-itTM Typhoid IgM test
3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Systematic Review on Antimicrobial Resistance amongThe American journal of tropical medicine and hygiene · 2020
    Pooled it
  4. Pooled it
  5. Global Typhoid Fever Incidence: A Systematic Review and Meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. A Review of the Human Health Risks from Microbial Hazards in Recreational Beach Sand.International journal of environmental research and public health · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Emergence of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

John A CrumpCentre for International Health, University of Otago, Dunedin, New Zealand.

Funding

Investigating Febrile Deaths in Tanzania (INDITe)R01AI121378 · NIAID · DUKE UNIVERSITY · PI RUBACH, MATTHEW P · 2016 to 2020
$2.7M
The Impact and Society Ecology of Bacterial Zoonoses in Northern Tanzania: UnderR01TW009237 · FIC · DUKE UNIVERSITY · PI CRUMP, JOHN ANDREW · 2011 to 2014
$1.7M
Biotechnology and Biological Sciences Research Council BB/J010367/1Biotechnology and Biological Sciences Research Council BB/L017679Biotechnology and Biological Sciences Research Council BB/L018845Biotechnology and Biological Sciences Research Council BB/L018926Biotechnology and Biological Sciences Research Council BB/L018926/1FIC NIH HHS R01 TW009237NIAID NIH HHS R01 AI121378
6 · The paper itself

Abstract

Salmonella enterica subspecies enterica serovar Typhi (Salmonella Typhi) is the cause of typhoid fever and a human host-restricted organism. Our understanding of the global burden of typhoid fever has improved in recent decades, with both an increase in the number and geographic representation of high-quality typhoid fever incidence studies, and greater sophistication of modeling approaches. The 2017 World Health Organization Strategic Advisory Group of Experts on Immunization recommendation for the introduction of typhoid conjugate vaccines for infants and children aged >6 months in typhoid-endemic countries is likely to require further improvements in our understanding of typhoid burden at the global and national levels. Furthermore, the recognition of the critical and synergistic role of water and sanitation improvements in concert with vaccine introduction emphasize the importance of improving our understanding of the sources, patterns, and modes of transmission of Salmonella Typhi in diverse settings.

Indexed as

Global HealthChild, PreschoolDisease ReservoirsHumansIncidenceInfantPractice Guidelines as TopicTyphoid FeverTyphoid-Paratyphoid VaccinesTyphoid-Paratyphoid VaccinesdeathepidemiologyincidenceSalmonellatyphoid fever

Identifiers

PMID30767000
PMCPMC6376096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.